Credit Suisse Ag Iveric Bio, Inc. Transaction History

Credit Suisse Ag

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$26.24 - $39.63 $2.79 Million - $4.21 Million	106,193 Added 90.15%	223,993 $8.81 Million
Q1 2023 May 10, 2023	BUY	$18.67 - $24.56 $228,464 - $300,540	12,237 Added 11.59%	117,800 $2.87 Million
Q4 2022 Feb 13, 2023	BUY	$17.24 - $23.95 $415,449 - $577,147	24,098 Added 29.58%	105,563 $2.26 Million
Q3 2022 Nov 10, 2022	BUY	$9.4 - $18.59 $76,234 - $150,764	8,110 Added 11.06%	81,465 $1.46 Million
Q2 2022 Aug 12, 2022	BUY	$9.12 - $18.9 $114,127 - $236,514	12,514 Added 20.57%	73,355 $706,000

Q1 2022 May 16, 2022	BUY	$12.15 - $16.83 $65,585 - $90,848	5,398 Added 9.74%	60,841 $1.02 Million
Q4 2021 Feb 14, 2022	BUY	$13.83 - $18.78 $185,515 - $251,914	13,414 Added 31.92%	55,443 $927,000
Q3 2021 Nov 12, 2021	BUY	$7.07 - $17.5 $90,340 - $223,615	12,778 Added 43.68%	42,029 $683,000
Q2 2021 Aug 16, 2021	SELL	$5.69 - $7.17 $181,533 - $228,751	-31,904 Reduced 52.17%	29,251 $184,000
Q1 2021 May 14, 2021	SELL	$5.08 - $6.89 $317,088 - $430,066	-62,419 Reduced 50.51%	61,155 $379,000
Q4 2020 Feb 12, 2021	BUY	$5.65 - $7.66 $698,193 - $946,576	123,574 New	123,574 $854,000
Q2 2020 Aug 12, 2020	SELL	$3.06 - $6.6 $99,030 - $213,595	-32,363 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$2.83 - $8.44 $170,145 - $507,429	-60,122 Reduced 65.01%	32,363 $111,000
Q4 2019 Feb 12, 2020	BUY	$0.93 - $8.58 $86,011 - $793,521	92,485 New	92,485 $794,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.